Hitchcock A, Topham S, Bell J, Gullick W, Elston C W, Ellis I O
Department of Histopathology, City Hospital, Nottingham, England.
Am J Surg Pathol. 1992 Jan;16(1):58-61. doi: 10.1097/00000478-199201000-00008.
This study compares the diagnostic reliability of conventional mucin histochemistry and immunocytochemical techniques in distinguishing mammary Paget's disease from superficial spreading malignant melanoma and primary intraepidermal carcinoma. Formalin-fixed, paraffin-embedded archival tissue was used and comprised 13 cases of mammary Paget's disease, five cases of superficial spreading melanoma, and six cases of intraepidermal carcinoma. Sections from each case were stained for the presence of mucin using diastase periodic-acid-Schiff (d-PAS) with and without an alcian blue counterstain as well as immunocytochemistry for cytokeratin (CAM 5.2), epithelial membrane antigen (NCRC-11) and c-erb B-2 (21N). Mucin staining in intraepidermal carcinoma and malignant melanoma was consistently negative. Diastase-resistant PAS positivity was seen in six of 13 cases of mammary Paget's disease and eight of 13 cases using an alcian blue counterstain. NCRC-11 showed positive immunoreactivity in four of six cases of intraepidermal carcinoma, one in five cases of melanoma, and five of 13 cases of mammary Paget's disease. Positive immunoreactivity using CAM 5.2 and 21N was seen in all cases of mammary Paget's disease, with consistent negative immunoreactivity in the other tumor types. We conclude that CAM 5.2 and 21N should be used in the investigation of mammary Paget's disease in preference to conventional mucin stains.
本研究比较了传统粘蛋白组织化学和免疫细胞化学技术在鉴别乳腺派杰氏病与浅表扩散性恶性黑色素瘤及原发性表皮内癌时的诊断可靠性。使用了福尔马林固定、石蜡包埋的存档组织,包括13例乳腺派杰氏病、5例浅表扩散性黑色素瘤和6例表皮内癌。对每个病例的切片进行染色,采用淀粉酶消化过碘酸希夫染色法(d-PAS)检测粘蛋白的存在,同时使用阿尔辛蓝复染或不复染,以及对细胞角蛋白(CAM 5.2)、上皮膜抗原(NCRC-11)和c-erb B-2(21N)进行免疫细胞化学检测。表皮内癌和恶性黑色素瘤的粘蛋白染色始终为阴性。在13例乳腺派杰氏病中,6例出现抗淀粉酶PAS阳性,使用阿尔辛蓝复染时13例中有8例阳性。NCRC-11在6例表皮内癌中有4例呈阳性免疫反应,5例黑色素瘤中有1例阳性,13例乳腺派杰氏病中有5例阳性。使用CAM 5.2和21N时,所有乳腺派杰氏病病例均呈阳性免疫反应,而其他肿瘤类型则始终呈阴性免疫反应。我们得出结论,在乳腺派杰氏病的研究中,应优先使用CAM 5.2和21N,而非传统的粘蛋白染色。